Dr. Nel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Medical Plaza
#365,530,420,120
Los Angeles, CA 90095Phone+1 310-825-6620
Education & Training
- Medical University of South Carolina College of MedicineFellowship, Allergy and Immunology, 1983 - 1985
- Stellenbosch University Faculty of MedicineClass of 1975
Certifications & Licensure
- CA State Medical License 1989 - 2027
- SC State Medical License 1986 - 1987
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 1993
Publications & Presentations
PubMed
- 2 citationsThe Interplay Between the Immune System, Tumor Suppressor Genes, and Immune Senescence in Mesothelioma Development and Response to Immunotherapy.Andre E Nel, Elizabeth N Pavlisko, Victor L Roggli
Journal of Thoracic Oncology. 2024-04-01 - Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor.Lijia Luo, Xiang Wang, Yu-Pei Liao, Xiao Xu, Chong Hyun Chang
Nano Today. 2024-02-01 - Correction to "Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunothera...Lijia Luo, Xiang Wang, Yu-Pei Liao, Chong Hyun Chang, Andre E Nel
ACS Nano. 2023-08-08
Journal Articles
- Nano-Enabled Pancreas Cancer Immunotherapy Using Immunogenic Cell Death and Reversing ImmunosuppressionAndre Nel, MD, Nature
Press Mentions
- Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and AbbottSeptember 17th, 2021
- UCLA Researchers Use Nanoparticles to Develop Treatment for AllergiesFebruary 7th, 2021
- Hitting Target in Cancer Fight Now Easier with New Nanoparticle Platform, Scientists SayMay 5th, 2011
- Join now to see all
Grant Support
- Project 2: Relating Enm Physicochemical Properties To Mechanism-Based Pulmonary TNational Institute Of Environmental Health Sciences2010–2012
- Center For Nanobiology And Predictive ToxicologyNational Institute Of Environmental Health Sciences2010–2012
- Administrative CoreNational Institute Of Environmental Health Sciences2010–2012
- Nanovalve Platform: Targeted, Controlled, Release Of Anticancer DrugsNational Cancer Institute2010–2012
- Nano-Biological Interactions And Toxicity Of Engineered Metal Oxide ParticlesNational Institute Of Environmental Health Sciences2008–2012
- Predictive Toxicological Paradigms To Establish Inhalation Toxicology ModelsNational Institute Of Environmental Health Sciences2009–2010
- PM Adjuvant Effects, Dendritic Cells And Hierarchical, Oxidative Stress ResponseNational Institute Of Allergy And Infectious Diseases2007–2010
- Xenobiotics, Oxidative Stress And Allergic InflammationNational Institute Of Allergy And Infectious Diseases2006–2010
- Administrative, Subject Recruitment And Sample Coordination CoreNational Institute Of Allergy And Infectious Diseases2006–2010
- Development Of Methods And Models For Nanoparticle Toxicity Screening: ApplicatioNational Institute Of Environmental Health Sciences2006–2008
- Atherogenic Effects Of Ambient PM In Susceptible AnimalsNational Institute Of Environmental Health Sciences2004–2007
- PM Adjuvant Effects, Dendritic Cells Oxidative StressNational Institute Of Allergy And Infectious Diseases2006
- Lipids Rafts In JNK And Nk-Kb Activation By TCR/CD28National Institute On Aging2002–2006
- Proteomics Of Dep-Induced Oxidative StressNational Institute Of Environmental Health Sciences2002–2006
- Biological Analysis Of Toxic DEP ChemicalsNational Institute Of Environmental Health Sciences2002–2006
- Allergy, Immunology &Transplantation Research CommitteeNational Institute Of Allergy And Infectious Diseases2004–2005
- Core--Diesel Exhaust Collection And FractionationNational Institute Of Allergy And Infectious Diseases2001–2002
- Airway Oxidant Stress Response To DEP XenobioticsNational Institute Of Allergy And Infectious Diseases2001–2002
- Mapkinase Cascades And T Cell Decision MakingNational Institute On Aging1998–2001
- Xenobiotic Effects On Allergic Responses VIA MacrophagesNational Institute Of Allergy And Infectious Diseases1997–2000
- Cytokine And Growth Factor Pathways In Kaposis SarcomaNational Cancer Institute1994–1998
- MAPK Cascades And Function Decline Of Aged T CellsNational Institute On Aging1997
- Signaling Pathways In IGE Production--Effect Of AdjuvantsNational Institute Of Allergy And Infectious Diseases1994–1996
- PKC And Tyrosine Kinases Synergize In T-Cell ActivationNational Institute Of General Medical Sciences1992–1995
- Ibd--Biochemical Pathways In Mucosal T Cell ActivationNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
- Tyrosine And C-Kinase Activity And PI Turnover In T-CellNational Institute Of General Medical Sciences1988–1990
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: